1246 — Boill Healthcare Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$32.59m
- HK$873.62m
- HK$285.20m
Annual income statement for Boill Healthcare Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 106 | 217 | 1,005 | 348 | 285 |
| Cost of Revenue | |||||
| Gross Profit | 10.8 | 19 | 110 | 0.11 | 11.7 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 222 | 274 | 941 | 529 | 539 |
| Operating Profit | -116 | -57.1 | 63.4 | -181 | -254 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -203 | -181 | -2.39 | -225 | -276 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -224 | -175 | -11.3 | -227 | -283 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -189 | -142 | -518 | -428 | -119 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -189 | -142 | -518 | -428 | -119 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.2 | -0.133 | -0.008 | -0.165 | -0.094 |